4.7 Letter

Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD

Journal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 36, Issue 5, Pages 499-500

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1365-2036.2012.05204.x

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available